<DOC>
	<DOCNO>NCT00004450</DOCNO>
	<brief_summary>OBJECTIVES : I . Evaluate efficacy interferon beta thalidomide male patient adrenoleukodystrophy show evidence brain inflammatory response receive concurrent glyceryl trierucate glyceryl trioleate ( Lorenzo 's oil ) . II . Evaluate progress disease possible side effect medication patient .</brief_summary>
	<brief_title>Randomized Study Beta Interferon Thalidomide Patients With Adrenoleukodystrophy</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double blind , placebo control study . Patients randomize receive beta interferon thalidomide placebo ( arm I ) , thalidomide beta interferon placebo ( arm II ) , placebo beta interferon thalidomide ( arm III ) . Patients receive interferon beta subcutaneous injection thalidomide orally . All patient maintain glyceryl trierucate glyceryl trioleate ( Lorenzo 's oil ) therapy . Patients follow 3 , 6 , 12 month may follow every 6 month thereafter .</detailed_description>
	<mesh_term>Adrenoleukodystrophy</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Adrenoleukodystrophy ( ALD ) diagnosis base history examination , MRI , biochemical assay Clinical evidence rapidly progressive phase cerebral ALD must include 2 follow precede year : Significant progressive impairment school performance Significant loss cognitive function lead IQ 75 less Progressive impairment ability understand speak word Progressive impairment vision Progressive deterioration handwrite Progressive difficulty walk Progressive impairment speech articulation , vocabulary Progressive weakness one limb Must MRI abnormalities characteristic cerebral ALD , especially evidence breakdown bloodbrain barrier use gadolinium contrast medium magnetization transfer technique Evidence brain white matter inflammatory response Must meet criterion bone marrow transplantation Not apparent vegetative state Prior/Concurrent Therapy Concurrent glyceryl trierucate glyceryl trioleate ( Lorenzo 's oil ) therapy require Patient Characteristics Effective contraception require patient</criteria>
	<gender>Male</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2001</verification_date>
	<keyword>adrenoleukodystrophy</keyword>
	<keyword>inborn error metabolism</keyword>
	<keyword>rare disease</keyword>
	<keyword>sphingolipidoses</keyword>
</DOC>